Question 1

What are the differences between the subcutaneous and intravenous forms of rituximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma clinical trial (NCT00930514). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial help in my treatment plan for follicular lymphoma?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma clinical trial (NCT00930514). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma clinical trial (NCT00930514). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma clinical trial (NCT00930514). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma clinical trial (NCT00930514). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma clinical trial (NCT00930514). Contact the study team or your healthcare provider for specific answers.

What this study is about